GCC2005
GCC2005A-P101
Phase 1 small_molecule active
Quick answer
GCC2005 for Lymphoma, T-Cell is a Phase 1 program (small_molecule) at Artiva Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Artiva Biotherapeutics
- Indication
- Lymphoma, T-Cell
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active